Range
3.47 - 3.62
Vol / Avg.
631.4K/883.1K
Div / Yield
-
52 Wk
1.44 - 11.2
Mkt Cap
184.5M
Payout Ratio
-
Open
3.55
P/E
-
EPS
-0.42
Shares
51.4M
Outstanding
51.4M
Total Float
45.2M
Benzinga - 6 days ago
Benzinga - Jun 10, 2021, 1:25PM
Benzinga - Jun 8, 2021, 3:33PM
Benzinga - May 7, 2021, 6:50AM
Benzinga - May 6, 2021, 12:41PM
Benzinga - May 6, 2021, 7:21AM
Benzinga - Apr 6, 2021, 9:35AM
Benzinga - Mar 16, 2021, 4:42PM
Benzinga - Mar 16, 2021, 3:08PM
Benzinga - Mar 4, 2021, 8:28AM
Benzinga - Mar 4, 2021, 7:09AM
Benzinga - Mar 1, 2021, 8:07AM
Benzinga - Feb 11, 2021, 8:11AM
load more
Sector: Health Care.Industry: Pharmaceuticals
VYNE Therapeutics Inc is a biopharmaceutical company which focuses on the development and commercialization of variety of solutions using its proprietary Molecule Stabilizing Technology. The company is developing products which will help improve lives of the patients with dermatological diseases. Its pipeline includes Amzeeq and Zilxi.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-0.410-0.370 0.0400
REV5.310M4.119M-1.191M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
VYNEVYNE Therapeutics0.28%184.5M

VYNE Therapeutics Frequently Asked Questions

Q

How do I buy VYNE Therapeutics (VYNE) stock?

A

You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are VYNE Therapeutics's (VYNE) competitors?

A

Other companies in VYNE Therapeutics’s space includes: Xeris Pharmaceuticals (NASDAQ:XERS), Satsuma Pharmaceuticals (NASDAQ:STSA), SCYNEXIS (NASDAQ:SCYX), Jaguar Health (NASDAQ:JAGX) and Tricida (NASDAQ:TCDA).

Q

What is the target price for VYNE Therapeutics (VYNE) stock?

A

The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on May 7, 2021. The analyst firm set a price target for 11.00 expecting VYNE to rise to within 12 months (a possible 206.41% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for VYNE Therapeutics (VYNE)?

A

The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.59 last updated Tue Jun 22 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does VYNE Therapeutics (VYNE) pay a dividend?

A

There are no upcoming dividends for VYNE Therapeutics.

Q

When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?

A
VYNE Therapeutics’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is VYNE Therapeutics (VYNE) going to split?

A

There is no upcoming split for VYNE Therapeutics.

Q

What sector and industry does VYNE Therapeutics (VYNE) operate in?

A

VYNE Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.